EUVIMEDEUVIMED entdecken
Crossref

Targeted Degradation of ZBP1 with Covalent PROTACs for Anti‐Inflammatory Treatment of Infections

Rentang Huang, Yusi Hu, Yi-Fan Wang, Shiyu Zhang, Zhi-Gang Wang, Dai-Wen Pang, Shu-Lin Liu

Angewandte Chemie International Edition · 2025

DOI: 10.1002/anie.202423524 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Angewandte Chemie International Edition, 2025. Verfasst von Rentang Huang und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Medicinal Chemical Biology, Frontiers Science Centre for New Organic Matter, Tianjin Key Laboratory of Biosensing and Molecul…. Hauptthemen laut MEDLINE: Aptamers, Nucleotide, Anti-Inflammatory Agents, DNA-Binding Proteins, Sulfonamides. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Z‐DNA binding protein 1 (ZBP1) has emerged as a critical pathogen‐sensing protein that upon activation, triggers necroptotic signaling cascades, leading to a potent inflammatory response and potentially causing significant tissue damage. However, available drugs specifically developed for the effective inhibition or degradation of ZBP1 is still lacking so far. In this study, we developed a potent covalent recognition‐based PROTAC (C‐PROTAC) molecule for the degradation of ZBP1. It consists of a DNA aptamer as the recognition moiety and an E3 enzyme‐recruiting unit, connected by a linker containing N ‐acyl‐ N ‐alkyl sulfonamides (NASA) groups. The DNA aptamer specifically binds to ZBP1, while the NASA‐containing linker facilitates the formation of a covalent bond between the PROTAC and the target protein. The E3 ligase‐recruiting unit then directs the ubiquitin‐proteasome system to degrade the ZBP1‐PROTAC complex. This approach combines the high specificity of DNA aptamers with the efficiency of covalent binding and the degradation‐inducing capabilities of PROTACs, providing a powerful tool for targeted protein degradation. The successful application of this technology to ZBP1 highlights its potential for the selective elimination of disease‐associated proteins and the development of novel therapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aptamers, NucleotideAnti-Inflammatory AgentsDNA-Binding ProteinsSulfonamidesHumansProteolysisAnimalsUbiquitin-Protein LigasesMiceProteolysis Targeting Chimera

Stichwörter der Autor:innen

Anti‐Inflammatory treatmentCovalent PROTACsInfectionsTargeted degradationZBP1

Substanzen

Aptamers, NucleotideAnti-Inflammatory AgentsDNA-Binding ProteinsSulfonamidesUbiquitin-Protein LigasesProteolysis Targeting Chimera

Autor:innen und Institutionen

  • State Key Laboratory of Medicinal Chemical Biology, Frontiers Science Centre for New Organic Matter, Tianjin Key Laboratory of Biosensing and Molecular Recognition, Research Centre for Analytical Sciences, College of Ch…

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Huang, R., Hu, Y., Wang, Y. F., Zhang, S., Wang, Z. G., Pang, D. W., & Liu, S. L. (2025). Targeted Degradation of ZBP1 with Covalent PROTACs for Anti‐Inflammatory Treatment of Infections. Angewandte Chemie International Edition. https://doi.org/10.1002/anie.202423524

Vancouver

Huang R, Hu Y, Wang YF, Zhang S, Wang ZG, Pang DW, et al. Targeted Degradation of ZBP1 with Covalent PROTACs for Anti‐Inflammatory Treatment of Infections. Angewandte Chemie International Edition. 2025. doi:10.1002/anie.202423524

BibTeX
@article{Huang2025,
  author = {Huang, Rentang and Hu, Yusi and Wang, Yi-Fan and Zhang, Shiyu and Wang, Zhi-Gang and Pang, Dai-Wen and Liu, Shu-Lin},
  title = {Targeted Degradation of ZBP1 with Covalent PROTACs for Anti‐Inflammatory Treatment of Infections},
  journal = {Angewandte Chemie International Edition},
  year = {2025},
  doi = {10.1002/anie.202423524}
}
Kostenlos starten →